S. Phipps

发表

Resistance to Pyrrolobenzodiazepine Dimers Is Associated with SLFN11 Downregulation and Can Be Reversed through Inhibition of ATR

R. Chaerkady, M. Cobbold, Herren Wu, 2021, Molecular Cancer Therapeutics.

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Ying Huang, P. Ryan, J. Jakubczak, 2004, Cancer Gene Therapy.

Fibronectin type III domains engineered to bind CD40L: cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of two complexes.

T. Thisted, V. Oganesyan, Stacey Drabic, 2013, Acta crystallographica. Section F, Structural biology and crystallization communications.

Crystallization and preliminary X-ray diffraction analysis of the complex of a human anti-ephrin type-A receptor 2 antibody fragment and its cognate antigen.

Herren Wu, Susan D. Wilson, V. Oganesyan, 2010, Acta crystallographica. Section F, Structural biology and crystallization communications.

Retroviral-mediated transfer and expression of the multidrug resistance protein 1 gene (MRP1) protect human hematopoietic cells from antineoplastic drugs.

C. K. Chan, A. Stewart, I. Dubé, 1999, Journal of hematotherapy & stem cell research.

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.

Ying Huang, P. Ryan, J. Jakubczak, 2003, Cancer research.

Inhibition of choroidal neovascularization by intravenous injection of adenoviral vectors expressing secretable endostatin.

P. Campochiaro, P. Gehlbach, M. Melia, 2001, The American journal of pathology.

Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.

C. Schnell, J. Jakubczak, P. Hallenbeck, 2000, Human gene therapy.

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma.

Y. Chiang, P. Hallenbeck, C. Hay, 1999, Human gene therapy.

Enhancing IgG distribution to lung mucosal tissue improves protective effect of anti-Pseudomonas aeruginosa antibodies.

Herren Wu, Michael P. McCarthy, Nurten Beyaz, 2018, JCI insight.

SLC46A3 as a Potential Predictive Biomarker for Antibody–Drug Conjugates Bearing Noncleavable Linked Maytansinoid and Pyrrolobenzodiazepine Warheads

M. Rebelatto, S. Sridhar, K. Papadopoulos, 2018, Clinical Cancer Research.

The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan

J. Hood, R. Dunmore, N. Bond, 2017, mAbs.

Preclinical evaluation of a GFRA1 targeted antibody-drug conjugate in breast cancer

J. Zha, Zhan Xiao, E. Bosco, 2018, Oncotarget.

A high yielding IFNAR1 ECD mammalian expression process for use in autoimmune disease drug development.

A. Hunter, Susan Wilson, S. Phipps, 2020, Protein expression and purification.

Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer

M. Cobbold, K. McGlinchey, S. Phipps, 2023, The Journal of clinical investigation.